Incidence and preoperative predictors for major complications following radical nephroureterectomy.

Upper tract urothelial carcinoma (UTUC) chronic kidney disease (CKD) major complications performance status radical nephroureterectomy (RNU)

Journal

Translational andrology and urology
ISSN: 2223-4691
Titre abrégé: Transl Androl Urol
Pays: China
ID NLM: 101581119

Informations de publication

Date de publication:
Aug 2020
Historique:
entrez: 18 9 2020
pubmed: 19 9 2020
medline: 19 9 2020
Statut: ppublish

Résumé

Radical nephroureterectomy (RNU) is the referent standard for managing bulky, invasive, or high grade upper-tract urothelial carcinoma (UTUC). The UTUC patient population, however, generally harbor medical comorbidities thereby placing them at risk of surgical complications. This study reviews a large international cohort of RNU patients to define the risk of major complications and preoperative factors associated with their occurrence. Patients undergoing RNU at 14 academic medical centers between 2002 and 2015 were retrospectively reviewed. Preoperative clinical, demographic, operative, and comorbidity indices were recorded. The modified Clavien-Dindo index was used to grade complications occurring within 30 days of surgery. The association between preoperative variables and major complications occurring after RNU was determined by multivariable logistic regression. One thousand two hundred and sixty-six patients (707 men; 559 women) with a median age of 70 years and BMI of 27 kg/m Major complications following RNU occurred in almost 10% of patients. Impaired preoperative performance status and baseline CKD are preoperative variables associated with these major post-surgical adverse event. These easily measurable indices warrant consideration and discussion prior to proceeding with RNU.

Sections du résumé

BACKGROUND BACKGROUND
Radical nephroureterectomy (RNU) is the referent standard for managing bulky, invasive, or high grade upper-tract urothelial carcinoma (UTUC). The UTUC patient population, however, generally harbor medical comorbidities thereby placing them at risk of surgical complications. This study reviews a large international cohort of RNU patients to define the risk of major complications and preoperative factors associated with their occurrence.
METHODS METHODS
Patients undergoing RNU at 14 academic medical centers between 2002 and 2015 were retrospectively reviewed. Preoperative clinical, demographic, operative, and comorbidity indices were recorded. The modified Clavien-Dindo index was used to grade complications occurring within 30 days of surgery. The association between preoperative variables and major complications occurring after RNU was determined by multivariable logistic regression.
RESULTS RESULTS
One thousand two hundred and sixty-six patients (707 men; 559 women) with a median age of 70 years and BMI of 27 kg/m
CONCLUSIONS CONCLUSIONS
Major complications following RNU occurred in almost 10% of patients. Impaired preoperative performance status and baseline CKD are preoperative variables associated with these major post-surgical adverse event. These easily measurable indices warrant consideration and discussion prior to proceeding with RNU.

Identifiants

pubmed: 32944541
doi: 10.21037/tau.2020.01.22
pii: tau-09-04-1786
pmc: PMC7475660
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1786-1793

Subventions

Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States

Informations de copyright

2020 Translational Andrology and Urology. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau.2020.01.22). The series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Références

Cancer Treat Rev. 2015 Apr;41(4):310-9
pubmed: 25736461
J Endourol. 2015 Sep;29(9):1052-8
pubmed: 25891843
Urology. 2011 Jul;78(1):61-7
pubmed: 21354598
Eur Urol. 2012 Jul;62(1):100-14
pubmed: 22381168
Int J Urol. 2019 Apr;26(4):487-492
pubmed: 30756440
BJU Int. 2011 Apr;107(7):1059-64
pubmed: 20825397
World J Urol. 2011 Aug;29(4):481-6
pubmed: 20886219
Eur Urol. 2018 Jan;73(1):111-122
pubmed: 28867446
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Eur Urol. 2012 Jun;61(6):1142-53
pubmed: 22349569
Eur J Surg Oncol. 2014 Dec;40(12):1629-34
pubmed: 25108813
Can J Urol. 2014 Aug;21(4):7369-73
pubmed: 25171281
BJU Int. 2012 Apr;109(8):1155-61
pubmed: 21883847
Cancer. 2009 Mar 15;115(6):1224-33
pubmed: 19156917
Urol Oncol. 2014 Jan;32(1):47.e9-14
pubmed: 24140248
BJU Int. 2017 Feb;119(2):268-275
pubmed: 27322735

Auteurs

Neil J Kocher (NJ)

Department of Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.

David Canes (D)

Department of Urology, Lahey Clinic Hospital and Medical Center, Burlington, MA, USA.

Karim Bensalah (K)

Department of Urology, University of Rennes, Rennes, France.

Morgan Roupret (M)

Department of Urology, Pierre and Marie Curie University, Paris, France.

Costas Lallas (C)

Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.

Vitaly Margulis (V)

Department of Urology, The University of Texas Southwestern, Dallas, TX, USA.

Shahrokh Shariat (S)

Department of Urology, Medical University of Vienna, Vienna, Austria.

Pierre Colin (P)

Department of Urology, La Louviere Private Hospital, Lille, France.

Surena Matin (S)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Chad Tracy (C)

Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Evanguelos Xylinas (E)

Department of Urology, Cochin Hospital, Paris, France.

Andrew Wagner (A)

Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Mathieu Roumiguie (M)

Department of Urology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Wassim Kassouf (W)

Department of Urology, McGill University Health Center, Montreal, Quebec, Canada.

Tobias Klatte (T)

Department of Urology, Medical University of Vienna, Vienna, Austria.

Jay D Raman (JD)

Department of Surgery, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.

Classifications MeSH